TR200102515T2 - Egzersiz kaynaklı astma tedavisi için metod. - Google Patents

Egzersiz kaynaklı astma tedavisi için metod.

Info

Publication number
TR200102515T2
TR200102515T2 TR2001/02515T TR200102515T TR200102515T2 TR 200102515 T2 TR200102515 T2 TR 200102515T2 TR 2001/02515 T TR2001/02515 T TR 2001/02515T TR 200102515 T TR200102515 T TR 200102515T TR 200102515 T2 TR200102515 T2 TR 200102515T2
Authority
TR
Turkey
Prior art keywords
exercise
treatment
induced asthma
asthma
induced
Prior art date
Application number
TR2001/02515T
Other languages
English (en)
Inventor
B. Christensen Siegfried
Nieman Richard
J. Torphy Theodore
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200102515T2 publication Critical patent/TR200102515T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bir PDE 4 inhibitörünün uygulanmasi ile egzersizden kaynaklanan astmanin tedavisine dair metodlar.
TR2001/02515T 1999-03-01 2000-03-01 Egzersiz kaynaklı astma tedavisi için metod. TR200102515T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12246499P 1999-03-01 1999-03-01
US14129199P 1999-06-28 1999-06-28

Publications (1)

Publication Number Publication Date
TR200102515T2 true TR200102515T2 (tr) 2002-04-22

Family

ID=26820540

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02515T TR200102515T2 (tr) 1999-03-01 2000-03-01 Egzersiz kaynaklı astma tedavisi için metod.

Country Status (19)

Country Link
US (1) US6555576B1 (tr)
EP (1) EP1156800A4 (tr)
JP (1) JP2002538115A (tr)
KR (1) KR20010102460A (tr)
CN (1) CN1350453A (tr)
AR (1) AR035987A1 (tr)
AU (1) AU3715000A (tr)
BR (1) BR0008625A (tr)
CA (1) CA2366041A1 (tr)
CO (1) CO5150236A1 (tr)
CZ (1) CZ20013148A3 (tr)
HK (1) HK1043727A1 (tr)
HU (1) HUP0200026A3 (tr)
IL (1) IL144996A0 (tr)
NO (1) NO20014221L (tr)
NZ (1) NZ513697A (tr)
PL (1) PL352822A1 (tr)
TR (1) TR200102515T2 (tr)
WO (1) WO2000051599A1 (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028986A1 (es) * 1999-02-23 2003-06-04 Smithkline Beecham Corp USO DE UN INHIBIDOR DE PDE4 EN LA FABRICACIoN DE UNA PREPARACIoN DE LIBERACIoN CONTROLADA; FORMULACION DE LIBERACION CONTROLADA PARA EL TRATAMIENTO DE COPD, UN PROCEDIMIENTO PARA SU PREPARACIoN Y COMPOSICIoN FARMACÉUTICA
DZ3249A1 (fr) * 1999-10-29 2001-05-10 Smithkline Beecham Corp Procédé d'administration d'un inhibiteur phosphodiesterase 4
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
PL393155A1 (pl) 2001-09-14 2011-03-28 Glaxo Group Limited Pochodne fenetanoloaminy do leczenia chorób układu oddechowego
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
PL377122A1 (pl) 2002-10-28 2006-01-23 Glaxo Group Limited Pochodne fenetanoloaminy do leczenia chorób układu oddechowego
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
JPWO2004087147A1 (ja) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 肺疾患の治療および／または予防剤
GB0317374D0 (en) 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
JP2007514665A (ja) * 2003-12-12 2007-06-07 ミオゲン インコーポレイティッド エノキシモン製剤ならびに心肥大および心不全の治療へのそれらの使用方法
WO2005092333A1 (en) * 2004-03-22 2005-10-06 Myogen, Inc. (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
US20060025463A1 (en) * 2004-03-22 2006-02-02 Michael Bristow Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
EP1776108A1 (en) * 2004-06-23 2007-04-25 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
GB0418278D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
UY29440A1 (es) 2005-03-25 2006-10-02 Glaxo Group Ltd Nuevos compuestos
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
GB0525337D0 (en) * 2005-12-13 2006-01-18 Novartis Ag Organic compounds
GB0622827D0 (en) 2006-11-15 2006-12-27 Glaxo Group Ltd Sheet driver for use in a drug dispenser
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
US20190307975A1 (en) 2016-11-21 2019-10-10 Lupin Inc. Medicament dispenser
WO2019195711A1 (en) 2018-04-06 2019-10-10 Lupin Inc. Medicament dispenser
WO2020058823A1 (en) 2018-09-17 2020-03-26 Lupin, Inc. Dose indicator assembly for a medicament dispenser
WO2021195353A1 (en) 2020-03-25 2021-09-30 Lupin Inc. Multi-carrier medicament dispensers
CN116210004A (zh) 2020-07-23 2023-06-02 鲁平股份有限公司 用于药剂分配器的剂量计数器组件

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552438A (en) 1992-04-02 1996-09-03 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases

Also Published As

Publication number Publication date
AR035987A1 (es) 2004-08-04
EP1156800A1 (en) 2001-11-28
EP1156800A4 (en) 2004-11-24
JP2002538115A (ja) 2002-11-12
BR0008625A (pt) 2002-02-19
CA2366041A1 (en) 2000-09-08
IL144996A0 (en) 2002-06-30
NO20014221L (no) 2001-10-24
CZ20013148A3 (cs) 2002-08-14
AU3715000A (en) 2000-09-21
NO20014221D0 (no) 2001-08-31
HUP0200026A3 (en) 2003-03-28
KR20010102460A (ko) 2001-11-15
PL352822A1 (en) 2003-09-08
HUP0200026A2 (hu) 2002-05-29
HK1043727A1 (zh) 2002-09-27
CO5150236A1 (es) 2002-04-29
NZ513697A (en) 2001-09-28
CN1350453A (zh) 2002-05-22
WO2000051599A1 (en) 2000-09-08
US6555576B1 (en) 2003-04-29

Similar Documents

Publication Publication Date Title
TR200102515T2 (tr) Egzersiz kaynaklı astma tedavisi için metod.
DE69516866D1 (de) Stereochemische wortmanninderivate
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
NO903944D0 (no) Fremgangsmaate for fremstilling av nye peptidase og isomerase-inhibitorer.
TR200200082T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
DE60120494D1 (de) Substituieten triazoldiamin derivaten und ihre verwendung als kinase inhibitoren
ATE360884T1 (de) Vorrichtung zum behandeln eines scheibenförmigen gegenstandes
NO996578L (no) Urokinase-inhibitorer
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
ATE231505T1 (de) Neue heterocyclische/cyclische amine
BG108181A (en) Novel spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
NZ330216A (en) Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and use in treatment of atherosclerosis
EA200001102A1 (ru) Способ синтеза ингибиторов сох-2 (циклооксигеназы-2)
DE69616333T2 (de) Thip zur behandlung von schlafstörungen
WO2001064676A3 (en) INHIBITORS OF p38-α KINASE
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
PT1250340E (pt) Metodos e compostos para inibicao de mrp1
DE60318826D1 (de) Alkoxypyridinderivate
ATE244712T1 (de) Piperazino-derivative als neurokininantagonisten
TR200102514T2 (tr) COPD tedavisi için metod
MY133014A (en) Method for treating copd
DE60117783D1 (de) Naphthamidin-urokinasinhibitoren
GB0028660D0 (en) Device for treating wood by means of steam